Alterity Therapeutics (FRA:PBN) FFO


FRA:PBN Alterity Therapeutics Ltd FRA:PBN
27 GF Score
Price €0.33
View Full Analysis

What is Alterity Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:PBN
27GF Score
Alterity Therapeutics Ltd FRA:PBN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alterity Therapeutics Business Description

Other Exchanges ATHE:USAATH:Australia
Address 350 Collins Street, Suite 4, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
27GF Score

Get the complete analysis for FRA:PBN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.33
Price